Skip to main content

Advertisement

SpringerLink
Log in

Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/objectives autoantibodies to types I and IV collagen have been described in rheumatic fever and infective endocarditis. We tried to elucidate if an autoimmune response against collagens I and IV exists, associated with heart valve disease in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). A cohort of 172 patients with SLE (n = 79), primary APS (PAPS, n = 83), and secondary APS (n = 10) were assessed for valvulopathy by transthoracic echocardiograms. Autoantibodies to types I and IV collagen were assessed in patients and 50 controls, setting autoantibody positivity at two standard deviations above the mean antibody level of controls. Positive anticollagen IV antibody rate was significantly higher in SLE patients (17.7%) in respect to the rest of groups (PAPS 2.4%, controls 2%; P = 0.001). Percentage of positive autoantibodies to collagen I was similar in SLE and APS cohort of patients with and without valvular disease (48.4 vs 51.6%, respectively; P = 0.45). Percentage of positive autoantibodies to collagen IV was increased but not significantly in SLE and APS cohort of patients with respect to those without valvular disease (62.5 vs 37.5%, respectively; P = 0.08). Mean (standard deviation) levels of positive anticollagen I and IV antibodies did not differ between patients with and without valvular disease (85.6 ± 55 vs 81 ± 85 U/ml, respectively; P = 0.86 for anticollagen I) (0.05 ± 0.02 vs 0.12 ± 0.16 U/ml, respectively; P = 0.34 for anticollagen IV). Our data indicate a lack of association of autoantibodies to types I and IV collagen with heart valve disease in SLE and APS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Libman E, Sacks B (1924) A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 33:701–737

    Article  Google Scholar 

  2. Cervera R, Tektonidou MG, Espinosa G et al. (2011) Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. Feb;20(2):165–73.

  3. Shapiro RF, Gamble CN, Wiesner KB, Castles JJ, Wolf AW, Hurley EJ, Salel AF et al (1977) Immunopathogenesis of Libman-Sacks endocarditis: assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis 36(6):508–516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69(6):849–858

    Article  CAS  PubMed  Google Scholar 

  5. Ziporen L, Goldberg I, Arad M et al (1996) Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5:196–205

    Article  CAS  PubMed  Google Scholar 

  6. Afek A, Schoenfeld Y, Manor R et al (1999) Increased endothelial cell expression of α3ß1 integrin in cardiac valvulopathy in primary (Hughes) and secondary antiphospholipid syndrome. Lupus 8:502–507

    Article  CAS  PubMed  Google Scholar 

  7. Weber KT (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13(7):1637–1652

    Article  CAS  PubMed  Google Scholar 

  8. Martins TB, Hoffman JL, Augustine NH et al (2008) Comprehensive analysis of antibodies responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int Immunol 20(39):445–452

    Article  CAS  PubMed  Google Scholar 

  9. De Buyzere ML, De Scheerder IK, Delanghe JR, Robbrecht JH, Clement DL, Wieme RJ (1989) Measurement of autoimmune response against collagen types I, III, and IV by ELISA, and its application in infective endocarditis. Clin Chem 35(2):246–250

    CAS  PubMed  Google Scholar 

  10. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  11. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  12. Pardos-Gea J, Ordi-Ros J, Avegliano G et al (2010) Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients. Lupus 19:575–582

    Article  CAS  PubMed  Google Scholar 

  13. Choi EK, Gatenby PA, McGill NW, Bateman JF, Cole WG, York JR (1988) Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue disease, and chronic inflammatory syndromes. Annals of the Rheumatic Disease 47:313–322

    Article  CAS  Google Scholar 

  14. Stuart JM, Huffstutter EH, Townes AS, Kang AH (1983) Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic disease as measured by I 125-radioimmunoassay. Arthritis Rheum 26:832–840

    Article  CAS  PubMed  Google Scholar 

  15. Cook AD, Rowley MJ, Wines BD, Mackay IR (1994) Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis. J Autoimmun 7(3):369–378

    Article  CAS  PubMed  Google Scholar 

  16. Cook AD, Mackay IR, Cicuttini FM, Rowley MJ (1997) IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 24(11):2090–2096

    CAS  PubMed  Google Scholar 

  17. Manivel VA, Sohrabian A, Wick MC, Mullazehi M, Håkansson LD, Rönnelid J (2015) Anti-type II collagen immune complex-induced granulocyte reactivity is associated with joint erosions in RA patients with anti-collagen antibodies. Arthritis Res Ther 17:8

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cui Z, Zhao MH, Jia XY, Wang M, Hu SY, Wang SX, Yu F, Brown KL, Hudson BG, Pedchenko V (2016) Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture’s disease. J Autoimmun 70:1–11

    Article  CAS  PubMed  Google Scholar 

  19. Petty RE, Hunt DW, Rosenberg AM (1986) Antibodies to type IV collagen in rheumatic diseases. J Rheumatol 13(2):246–253

    CAS  PubMed  Google Scholar 

  20. Mackel AM, de Lustro F, Harper FE, Le Roy EC (1982) Antibodies to collagen in scleroderma. Arthritis Rheum 25:522–531

    Article  CAS  PubMed  Google Scholar 

  21. Moreland LW, Gay RE, Gay S (1991) Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus. Clin Immunol Immunopathol 60(3):412–418

    Article  CAS  PubMed  Google Scholar 

  22. Fukasawa Y, Kano S (1993) Anti-type II collagen antibodies in collagen disease. Rinsho Byori 41(8):876–881

    CAS  PubMed  Google Scholar 

  23. Sjoholm AG, Martensson U, Sturfelt G (1997) Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 24(5):871–878

    CAS  PubMed  Google Scholar 

  24. Blank M, Krause I, Magrini L et al (2006) Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology 45:833–841

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Autoimmune Diseases Unit, Vall Hebrón University Hospital, Universidad Autonoma de Barcelona, Pg. Vall d’Hebrón 119-129, 08035, Barcelona, Spain

    José Pardos-Gea, Josefina Cortés-Hernández, Jesus Castro-Marrero, Eva Balada & José Ordi-Ros

Authors
  1. José Pardos-Gea
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josefina Cortés-Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jesus Castro-Marrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eva Balada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. José Ordi-Ros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José Pardos-Gea.

Ethics declarations

The appropriate institutional review boards approved this study, and all patients provided their informed consent.

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pardos-Gea, J., Cortés-Hernández, J., Castro-Marrero, J. et al. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome. Clin Rheumatol 36, 1401–1406 (2017). https://doi.org/10.1007/s10067-017-3594-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3594-9

Keywords

Search

Navigation